XML 20 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balances at Dec. 31, 2016 $ 15 $ 236,216 $ (240,610) $ (4,379)
Balances (in shares) at Dec. 31, 2016 14,977,397      
Issuance of stock in connection with financing agreement $ 9,315 12 12
Return of shares of stock by advisor (40,000)
Beneficial conversion feature of Advance Notes      
Beneficial conversion feature of Convertible Notes      
Issuance of stock options for payment of accrued compensation      
Stock-based compensation expense 2,115 2,115
Write down in fair value of warrants (97) (97)
Issuance of common stock in lieu of cash compensation      
Comprehensive loss (21,987) (21,987)
Balances at Dec. 31, 2017 $ 15 238,246 (262,597) (24,336)
Balances (in shares) at Dec. 31, 2017 14,946,712      
Conversion of notes payable and related accrued interest and fees to common stock $ 76 18,356 18,432
Conversion of notes payable and related accrued interest and fees to common stock (in shares) 76,007,754      
Issuance of common stock, net of issuance costs $ 19 2,762 2,781
Issuance of common stock, net of issuance costs (in shares) 18,653,320      
Beneficial conversion feature of Advance Notes 271 271
Beneficial conversion feature of Convertible Notes 1,465 1,465
Issuance of stock options for payment of accrued compensation 303 303
Stock-based compensation expense 4,812 4,812
Write down in fair value of warrants      
Issuance of common stock in lieu of cash compensation 151,407 85 85
Issuance of common stock in exchange for services 113,333 81 81
Comprehensive loss (12,004) (12,004)
Balances at Dec. 31, 2018 $ 110 $ 266,381 $ (274,601) $ (8,110)
Balances (in shares) at Dec. 31, 2018 109,872,526